Investigators at the Perelman School of Medicine at the University of Pennsylvania. say they have reached some new insights into the structure of a protein complex that is a root cause of a clotting disorder (heparin-induced thrombocytopenia) that strikes patients who receive the anti-clotting drug heparin. Their work was published in Nature Communications. Release